Cargando…
Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Association for the Study of Lung Cancer. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678031/ https://www.ncbi.nlm.nih.gov/pubmed/34930606 http://dx.doi.org/10.1016/j.jtho.2021.10.002 |
| _version_ | 1784616264070594560 |
|---|---|
| author | Masago, Katsuhiro Fujita, Shiro |
| author_facet | Masago, Katsuhiro Fujita, Shiro |
| author_sort | Masago, Katsuhiro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8678031 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | International Association for the Study of Lung Cancer. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86780312021-12-17 Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment Masago, Katsuhiro Fujita, Shiro J Thorac Oncol Editorial International Association for the Study of Lung Cancer. Published by Elsevier Inc. 2022-01 2021-12-17 /pmc/articles/PMC8678031/ /pubmed/34930606 http://dx.doi.org/10.1016/j.jtho.2021.10.002 Text en © 2021 International Association for the Study of Lung Cancer. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Editorial Masago, Katsuhiro Fujita, Shiro Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment |
| title | Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment |
| title_full | Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment |
| title_fullStr | Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment |
| title_full_unstemmed | Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment |
| title_short | Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment |
| title_sort | effect of coronavirus disease 2019 vaccine-related lymphadenopathy on lung cancer treatment |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678031/ https://www.ncbi.nlm.nih.gov/pubmed/34930606 http://dx.doi.org/10.1016/j.jtho.2021.10.002 |
| work_keys_str_mv | AT masagokatsuhiro effectofcoronavirusdisease2019vaccinerelatedlymphadenopathyonlungcancertreatment AT fujitashiro effectofcoronavirusdisease2019vaccinerelatedlymphadenopathyonlungcancertreatment |